Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice

γ-aminobutyric acid (GABA) or glucagon-like peptide-1 based drugs, such as sitagliptin (a dipeptidyl peptidase-4 inhibitor), were shown to induce beta cell regenerative effects in various diabetic mouse models. We propose that their combined administration can bring forth an additive therapeutic eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenjuan, Son, Dong Ok, Lau, Harry K., Zhou, Yinghui, Prud’homme, Gerald J., Jin, Tianru, Wang, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476705/
https://www.ncbi.nlm.nih.gov/pubmed/28676760
http://dx.doi.org/10.3389/fphar.2017.00362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476705/
https://www.ncbi.nlm.nih.gov/pubmed/28676760
http://dx.doi.org/10.3389/fphar.2017.00362

Ejemplares similares